Industry Research Reports

Home > Reports > Medical Devices & Consumables > Hepatitis Viruses Rapid Tests- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Hepatitis Viruses Rapid Tests- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-02-25

Pages: 100 Pages

Report ld: 4282982

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Hepatitis Viruses Rapid Tests was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Hepatitis Viruses Rapid Tests are diagnostic tools used to detect the presence of hepatitis viruses (e.g., Hepatitis B and C) in a patient"s blood or serum quickly. These tests provide rapid results, making them valuable in screening and diagnosing hepatitis infections.

The market for hepatitis viruses rapid tests has witnessed growth due to the global focus on eliminating hepatitis as a public health threat. Increased awareness, particularly in regions with high hepatitis prevalence, has driven demand for rapid testing. Advances in technology have also improved the accuracy and ease of use of these tests, further fueling market growth.

This report aims to provide a comprehensive presentation of the global market for Hepatitis Viruses Rapid Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hepatitis Viruses Rapid Tests by region & country, by End User, and by Application.

The Hepatitis Viruses Rapid Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis Viruses Rapid Tests.

MARKET SEGMENTATION

By Company

GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Adult
Children

Segment by Application

Hospital
Medical Center

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Hepatitis Viruses Rapid Tests company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Hepatitis Viruses Rapid Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Hepatitis Viruses Rapid Tests in country level. It provides sigmate data by End User, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Hepatitis Viruses Rapid Tests Product Introduction

1.2 Global Hepatitis Viruses Rapid Tests Market Size Forecast (2020-2031)

1.3 Hepatitis Viruses Rapid Tests Market Trends & Drivers

1.3.1 Hepatitis Viruses Rapid Tests Industry Trends

1.3.2 Hepatitis Viruses Rapid Tests Market Drivers & Opportunity

1.3.3 Hepatitis Viruses Rapid Tests Market Challenges

1.3.4 Hepatitis Viruses Rapid Tests Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hepatitis Viruses Rapid Tests Players Revenue Ranking (2024)

2.2 Global Hepatitis Viruses Rapid Tests Revenue by Company (2020-2025)

2.3 Key Companies Hepatitis Viruses Rapid Tests Manufacturing Base Distribution and Headquarters

2.4 Key Companies Hepatitis Viruses Rapid Tests Product Offered

2.5 Key Companies Time to Begin Mass Production of Hepatitis Viruses Rapid Tests

2.6 Hepatitis Viruses Rapid Tests Market Competitive Analysis

2.6.1 Hepatitis Viruses Rapid Tests Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Hepatitis Viruses Rapid Tests Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Viruses Rapid Tests as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by End User

3.1 Introduction by End User

3.1.1 Adult

3.1.2 Children

3.2 Global Hepatitis Viruses Rapid Tests Sales Value by End User

3.2.1 Global Hepatitis Viruses Rapid Tests Sales Value by End User (2020 VS 2024 VS 2031)

3.2.2 Global Hepatitis Viruses Rapid Tests Sales Value, by End User (2020-2031)

3.2.3 Global Hepatitis Viruses Rapid Tests Sales Value, by End User (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Medical Center

4.2 Global Hepatitis Viruses Rapid Tests Sales Value by Application

4.2.1 Global Hepatitis Viruses Rapid Tests Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Hepatitis Viruses Rapid Tests Sales Value, by Application (2020-2031)

4.2.3 Global Hepatitis Viruses Rapid Tests Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Hepatitis Viruses Rapid Tests Sales Value by Region

5.1.1 Global Hepatitis Viruses Rapid Tests Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Hepatitis Viruses Rapid Tests Sales Value by Region (2020-2025)

5.1.3 Global Hepatitis Viruses Rapid Tests Sales Value by Region (2026-2031)

5.1.4 Global Hepatitis Viruses Rapid Tests Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

5.2.2 North America Hepatitis Viruses Rapid Tests Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

5.3.2 Europe Hepatitis Viruses Rapid Tests Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

5.4.2 Asia Pacific Hepatitis Viruses Rapid Tests Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

5.5.2 South America Hepatitis Viruses Rapid Tests Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

5.6.2 Middle East & Africa Hepatitis Viruses Rapid Tests Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hepatitis Viruses Rapid Tests Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

6.3 United States

6.3.1 United States Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

6.3.2 United States Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

6.3.3 United States Hepatitis Viruses Rapid Tests Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

6.4.2 Europe Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

6.4.3 Europe Hepatitis Viruses Rapid Tests Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

6.5.2 China Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

6.5.3 China Hepatitis Viruses Rapid Tests Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

6.6.2 Japan Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

6.6.3 Japan Hepatitis Viruses Rapid Tests Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

6.7.2 South Korea Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

6.7.3 South Korea Hepatitis Viruses Rapid Tests Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

6.8.2 Southeast Asia Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

6.8.3 Southeast Asia Hepatitis Viruses Rapid Tests Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Hepatitis Viruses Rapid Tests Sales Value, 2020-2031

6.9.2 India Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

6.9.3 India Hepatitis Viruses Rapid Tests Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 GSK

7.1.1 GSK Profile

7.1.2 GSK Main Business

7.1.3 GSK Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.1.4 GSK Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.1.5 GSK Recent Developments

7.2 Merck

7.2.1 Merck Profile

7.2.2 Merck Main Business

7.2.3 Merck Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.2.4 Merck Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.2.5 Merck Recent Developments

7.3 Sanofi

7.3.1 Sanofi Profile

7.3.2 Sanofi Main Business

7.3.3 Sanofi Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.3.4 Sanofi Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.3.5 Sanofi Recent Developments

7.4 Sinovac

7.4.1 Sinovac Profile

7.4.2 Sinovac Main Business

7.4.3 Sinovac Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.4.4 Sinovac Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.4.5 Sinovac Recent Developments

7.5 Zhejiang Pukang

7.5.1 Zhejiang Pukang Profile

7.5.2 Zhejiang Pukang Main Business

7.5.3 Zhejiang Pukang Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.5.4 Zhejiang Pukang Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.5.5 Zhejiang Pukang Recent Developments

7.6 Changchun Institute of Biological

7.6.1 Changchun Institute of Biological Profile

7.6.2 Changchun Institute of Biological Main Business

7.6.3 Changchun Institute of Biological Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.6.4 Changchun Institute of Biological Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.6.5 Changchun Institute of Biological Recent Developments

7.7 KM Biologics

7.7.1 KM Biologics Profile

7.7.2 KM Biologics Main Business

7.7.3 KM Biologics Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.7.4 KM Biologics Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.7.5 KM Biologics Recent Developments

7.8 IMBCA

7.8.1 IMBCA Profile

7.8.2 IMBCA Main Business

7.8.3 IMBCA Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.8.4 IMBCA Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.8.5 IMBCA Recent Developments

7.9 ChangSheng

7.9.1 ChangSheng Profile

7.9.2 ChangSheng Main Business

7.9.3 ChangSheng Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.9.4 ChangSheng Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.9.5 ChangSheng Recent Developments

7.10 Convac

7.10.1 Convac Profile

7.10.2 Convac Main Business

7.10.3 Convac Hepatitis Viruses Rapid Tests Products, Services and Solutions

7.10.4 Convac Hepatitis Viruses Rapid Tests Revenue (US$ Million) & (2020-2025)

7.10.5 Convac Recent Developments

8 Industry Chain Analysis

8.1 Hepatitis Viruses Rapid Tests Industrial Chain

8.2 Hepatitis Viruses Rapid Tests Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hepatitis Viruses Rapid Tests Sales Model

8.5.2 Sales Channel

8.5.3 Hepatitis Viruses Rapid Tests Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Hepatitis Viruses Rapid Tests Market Trends

Table 2. Hepatitis Viruses Rapid Tests Market Drivers & Opportunity

Table 3. Hepatitis Viruses Rapid Tests Market Challenges

Table 4. Hepatitis Viruses Rapid Tests Market Restraints

Table 5. Global Hepatitis Viruses Rapid Tests Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Hepatitis Viruses Rapid Tests Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Hepatitis Viruses Rapid Tests Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Hepatitis Viruses Rapid Tests Product Type

Table 9. Key Companies Time to Begin Mass Production of Hepatitis Viruses Rapid Tests

Table 10. Global Hepatitis Viruses Rapid Tests Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Viruses Rapid Tests as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Hepatitis Viruses Rapid Tests Sales Value by End User: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Hepatitis Viruses Rapid Tests Sales Value by End User (2020-2025) & (US$ Million)

Table 15. Global Hepatitis Viruses Rapid Tests Sales Value by End User (2026-2031) & (US$ Million)

Table 16. Global Hepatitis Viruses Rapid Tests Sales Market Share in Value by End User (2020-2025)

Table 17. Global Hepatitis Viruses Rapid Tests Sales Market Share in Value by End User (2026-2031)

Table 18. Global Hepatitis Viruses Rapid Tests Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Hepatitis Viruses Rapid Tests Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Hepatitis Viruses Rapid Tests Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Hepatitis Viruses Rapid Tests Sales Market Share in Value by Application (2020-2025)

Table 22. Global Hepatitis Viruses Rapid Tests Sales Market Share in Value by Application (2026-2031)

Table 23. Global Hepatitis Viruses Rapid Tests Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Hepatitis Viruses Rapid Tests Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Hepatitis Viruses Rapid Tests Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Hepatitis Viruses Rapid Tests Sales Value by Region (2020-2025) & (%)

Table 27. Global Hepatitis Viruses Rapid Tests Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Hepatitis Viruses Rapid Tests Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Hepatitis Viruses Rapid Tests Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Hepatitis Viruses Rapid Tests Sales Value, (2026-2031) & (US$ Million)

Table 31. GSK Basic Information List

Table 32. GSK Description and Business Overview

Table 33. GSK Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 34. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of GSK (2020-2025)

Table 35. GSK Recent Developments

Table 36. Merck Basic Information List

Table 37. Merck Description and Business Overview

Table 38. Merck Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 39. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of Merck (2020-2025)

Table 40. Merck Recent Developments

Table 41. Sanofi Basic Information List

Table 42. Sanofi Description and Business Overview

Table 43. Sanofi Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 44. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of Sanofi (2020-2025)

Table 45. Sanofi Recent Developments

Table 46. Sinovac Basic Information List

Table 47. Sinovac Description and Business Overview

Table 48. Sinovac Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 49. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of Sinovac (2020-2025)

Table 50. Sinovac Recent Developments

Table 51. Zhejiang Pukang Basic Information List

Table 52. Zhejiang Pukang Description and Business Overview

Table 53. Zhejiang Pukang Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 54. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of Zhejiang Pukang (2020-2025)

Table 55. Zhejiang Pukang Recent Developments

Table 56. Changchun Institute of Biological Basic Information List

Table 57. Changchun Institute of Biological Description and Business Overview

Table 58. Changchun Institute of Biological Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 59. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of Changchun Institute of Biological (2020-2025)

Table 60. Changchun Institute of Biological Recent Developments

Table 61. KM Biologics Basic Information List

Table 62. KM Biologics Description and Business Overview

Table 63. KM Biologics Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 64. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of KM Biologics (2020-2025)

Table 65. KM Biologics Recent Developments

Table 66. IMBCA Basic Information List

Table 67. IMBCA Description and Business Overview

Table 68. IMBCA Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 69. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of IMBCA (2020-2025)

Table 70. IMBCA Recent Developments

Table 71. ChangSheng Basic Information List

Table 72. ChangSheng Description and Business Overview

Table 73. ChangSheng Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 74. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of ChangSheng (2020-2025)

Table 75. ChangSheng Recent Developments

Table 76. Convac Basic Information List

Table 77. Convac Description and Business Overview

Table 78. Convac Hepatitis Viruses Rapid Tests Products, Services and Solutions

Table 79. Revenue (US$ Million) in Hepatitis Viruses Rapid Tests Business of Convac (2020-2025)

Table 80. Convac Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Hepatitis Viruses Rapid Tests Downstream Customers

Table 84. Hepatitis Viruses Rapid Tests Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Hepatitis Viruses Rapid Tests Product Picture

Figure 2. Global Hepatitis Viruses Rapid Tests Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Hepatitis Viruses Rapid Tests Sales Value (2020-2031) & (US$ Million)

Figure 4. Hepatitis Viruses Rapid Tests Report Years Considered

Figure 5. Global Hepatitis Viruses Rapid Tests Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Hepatitis Viruses Rapid Tests Revenue in 2024

Figure 7. Hepatitis Viruses Rapid Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Adult Picture

Figure 9. Children Picture

Figure 10. Global Hepatitis Viruses Rapid Tests Sales Value by End User (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Hepatitis Viruses Rapid Tests Sales Value Market Share by End User, 2024 & 2031

Figure 12. Product Picture of Hospital

Figure 13. Product Picture of Medical Center

Figure 14. Global Hepatitis Viruses Rapid Tests Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Hepatitis Viruses Rapid Tests Sales Value Market Share by Application, 2024 & 2031

Figure 16. North America Hepatitis Viruses Rapid Tests Sales Value (2020-2031) & (US$ Million)

Figure 17. North America Hepatitis Viruses Rapid Tests Sales Value by Country (%), 2024 VS 2031

Figure 18. Europe Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 19. Europe Hepatitis Viruses Rapid Tests Sales Value by Country (%), 2024 VS 2031

Figure 20. Asia Pacific Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 21. Asia Pacific Hepatitis Viruses Rapid Tests Sales Value by Region (%), 2024 VS 2031

Figure 22. South America Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 23. South America Hepatitis Viruses Rapid Tests Sales Value by Country (%), 2024 VS 2031

Figure 24. Middle East & Africa Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 25. Middle East & Africa Hepatitis Viruses Rapid Tests Sales Value by Country (%), 2024 VS 2031

Figure 26. Key Countries/Regions Hepatitis Viruses Rapid Tests Sales Value (%), (2020-2031)

Figure 27. United States Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 28. United States Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

Figure 29. United States Hepatitis Viruses Rapid Tests Sales Value by Application (%), 2024 VS 2031

Figure 30. Europe Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 31. Europe Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

Figure 32. Europe Hepatitis Viruses Rapid Tests Sales Value by Application (%), 2024 VS 2031

Figure 33. China Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 34. China Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

Figure 35. China Hepatitis Viruses Rapid Tests Sales Value by Application (%), 2024 VS 2031

Figure 36. Japan Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 37. Japan Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

Figure 38. Japan Hepatitis Viruses Rapid Tests Sales Value by Application (%), 2024 VS 2031

Figure 39. South Korea Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 40. South Korea Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

Figure 41. South Korea Hepatitis Viruses Rapid Tests Sales Value by Application (%), 2024 VS 2031

Figure 42. Southeast Asia Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

Figure 44. Southeast Asia Hepatitis Viruses Rapid Tests Sales Value by Application (%), 2024 VS 2031

Figure 45. India Hepatitis Viruses Rapid Tests Sales Value, (2020-2031) & (US$ Million)

Figure 46. India Hepatitis Viruses Rapid Tests Sales Value by End User (%), 2024 VS 2031

Figure 47. India Hepatitis Viruses Rapid Tests Sales Value by Application (%), 2024 VS 2031

Figure 48. Hepatitis Viruses Rapid Tests Industrial Chain

Figure 49. Hepatitis Viruses Rapid Tests Manufacturing Cost Structure

Figure 50. Channels of Distribution (Direct Sales, and Distribution)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Hepatitis Viruses Rapid Tests market? zhanKai

The top companies in the global Hepatitis Viruses Rapid Tests market are GSK、Merck、Sanofi.

Related Reports

Hepatitis Viruses Rapid Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hepatitis Viruses Rapid Tests was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 110
USD 3950.00
(Single User License)
Global Hepatitis Viruses Rapid Tests Market Research Report 2026
The global Hepatitis Viruses Rapid Tests market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 103
USD 2900.00
(Single User License)
Global Hepatitis Viruses Rapid Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hepatitis Viruses Rapid Tests market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-30
Pages: 117
USD 4900.00
(Single User License)
Global Hepatitis Viruses Rapid Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hepatitis Viruses Rapid Tests market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 80
USD 4250.00
(Single User License)
Global Hepatitis Viruses Rapid Tests Market Research Report 2025
The global market for Hepatitis Viruses Rapid Tests was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 80
USD 2900.00
(Single User License)
Global Hepatitis Viruses Rapid Tests Market Insights, Forecast to 2030
Hepatitis Viruses Rapid Tests are diagnostic tools used to detect the presence of hepatitis viruses (e.g., Hepatitis B and C) in a patient's blood or serum quickly. These tests provide rapid results, making them valuable in screening and diagnosing hepatitis infections.
Published Date: 2024-04-19
Pages: 114
USD 4900.00
(Single User License)
Hepatitis Viruses Rapid Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hepatitis Viruses Rapid Tests are diagnostic tools used to detect the presence of hepatitis viruses (e.g., Hepatitis B and C) in a patient's blood or serum quickly. These tests provide rapid results, making them valuable in screening and diagnosing hepatitis infections.
Published Date: 2024-01-16
Pages: 109
USD 3950.00
(Single User License)
Global Hepatitis Viruses Rapid Tests Market Research Report 2024
Hepatitis Viruses Rapid Tests are diagnostic tools used to detect the presence of hepatitis viruses (e.g., Hepatitis B and C) in a patient's blood or serum quickly. These tests provide rapid results, making them valuable in screening and diagnosing hepatitis infections.
Published Date: 2024-01-16
Pages: 80
USD 2900.00
(Single User License)

Hepatitis Viruses Rapid Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hepatitis Viruses Rapid Tests was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 110
USD 3950.00 (Single User License)
Global Hepatitis Viruses Rapid Tests Market Research Report 2026
The global Hepatitis Viruses Rapid Tests market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 103
USD 2900.00 (Single User License)
Global Hepatitis Viruses Rapid Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hepatitis Viruses Rapid Tests market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-30
Pages: 117
USD 4900.00 (Single User License)
Global Hepatitis Viruses Rapid Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hepatitis Viruses Rapid Tests market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 80
USD 4250.00 (Single User License)
Global Hepatitis Viruses Rapid Tests Market Research Report 2025
The global market for Hepatitis Viruses Rapid Tests was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 80
USD 2900.00 (Single User License)
Global Hepatitis Viruses Rapid Tests Market Insights, Forecast to 2030
Hepatitis Viruses Rapid Tests are diagnostic tools used to detect the presence of hepatitis viruses (e.g., Hepatitis B and C) in a patient's blood or serum quickly. These tests provide rapid results, making them valuable in screening and diagnosing hepatitis infections.
Published: 2024-04-19
Pages: 114
USD 4900.00 (Single User License)
Hepatitis Viruses Rapid Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hepatitis Viruses Rapid Tests are diagnostic tools used to detect the presence of hepatitis viruses (e.g., Hepatitis B and C) in a patient's blood or serum quickly. These tests provide rapid results, making them valuable in screening and diagnosing hepatitis infections.
Published: 2024-01-16
Pages: 109
USD 3950.00 (Single User License)
Global Hepatitis Viruses Rapid Tests Market Research Report 2024
Hepatitis Viruses Rapid Tests are diagnostic tools used to detect the presence of hepatitis viruses (e.g., Hepatitis B and C) in a patient's blood or serum quickly. These tests provide rapid results, making them valuable in screening and diagnosing hepatitis infections.
Published: 2024-01-16
Pages: 80
USD 2900.00 (Single User License)